| Supplier |
Ace Therapeutics |
| Product # |
NSC1045 |
| Pricing |
Inquiry
|
| Product Size |
50 µg
|
| Purity |
≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC.
|
| Product Type |
Proteins
|
| Synonyms |
FGF19 Protein, Human
|
| Endotoxin |
< 10 EU per mg protein.
|
| Activity |
Testing in progress
|
| Protein Construction |
A DNA sequence encoding the mature form of human FGF19 (O95750-1) (Phe27-Lys216) was expressed with a N-terminal Met.
|
| Accession# |
O95750-1
|
| Expressed Host |
E. coli
|
| Species |
Human
|
| Predicted N Terminal |
Met
|
| Molecule Mass |
The recombinant human FGF19 consists of 191 amino acids and predicts a molecular mass of 21.4 KDa. It migrates as an approximately 23 KDa band in SDS-PAGE under reducing conditions.
|
| Formulation |
Lyophilized from sterile PBS, pH 7.4.Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
|
| Shipping |
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
|
| Stability & Storage |
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
| Reconstitution |
A hardcopy of datasheet with reconstitution instructions is sent along with the products. Please refer to it for detailed information.
|